168759-64-6 Usage
General Description
7-Bromo-4-isochromanone is a chemical compound that belongs to the isochromanone family. It is a pale yellow solid that is primarily used as an intermediate in organic synthesis. 7-BROMO-4-ISOCHROMANONE has potential applications in pharmaceuticals and agrochemicals. It is known for its ability to act as a versatile precursor in the synthesis of various biologically active molecules. Additionally, 7-Bromo-4-isochromanone has been studied for its potential use in the development of novel drugs and as a building block in the creation of new chemical entities. Overall, this chemical compound plays a significant role in the field of organic chemistry and has the potential for various practical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 168759-64-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,7,5 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 168759-64:
(8*1)+(7*6)+(6*8)+(5*7)+(4*5)+(3*9)+(2*6)+(1*4)=196
196 % 10 = 6
So 168759-64-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H7BrO2/c10-7-1-2-8-6(3-7)4-12-5-9(8)11/h1-3H,4-5H2
168759-64-6Relevant articles and documents
HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF
-
Paragraph 0630; 0635, (2021/02/25)
The present invention relates to a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the treatment of various HAT-related diseases or conditions.
ALDOSTERONE SYNTHASE INHIBITORS
-
, (2016/06/28)
The present invention relates to compounds of the formulas (IA) and (IB) and pharmaceutically acceptable salts thereof, wherein A and R1 - R6, are as defined herein. The invention also relates to pharmaceutical compositions comprisin
BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY
-
Paragraph 0377, (2015/06/25)
The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.